
Sevginur Akdas
Articles
-
Jan 2, 2025 |
breakingcancernews.com | Sevginur Akdas
As 2024 comes to an end, it has been a year of remarkable discoveries alongside growing challenges in cancer research. A major study in The Lancet revealed a concerning trend: cancer rates are rising among generations born between the 1920s and 1990s. Notable increases were observed in cancers of the small intestine, kidney, and pancreas in both men and women, as well as liver and bile duct cancers, particularly in women.
-
Dec 3, 2024 |
breakingcancernews.com | Sevginur Akdas
Last week, I attended a fascinating meeting in Germany focused on the use of DNA language models to enhance our understanding of DNA damage. As someone deeply invested in the interplay of biology and technology, I was immediately intrigued by the concept. DNA damage and mutations are well-established drivers of cancer development, making this an impactful topic.
-
Nov 10, 2024 |
breakingcancernews.com | Sevginur Akdas
Cancer, due to the challenging paths through its diagnosis and treatment, is often exhausting for patients and their families. Traditional treatments like surgery, chemotherapy, and radiation therapy can take a physical and emotional toll on patients, along with serious side effects. But recent technological advances are beginning to change the outlook for noninvasive cancer treatments, offering less aggressive, targeted therapies that reduce these side effects.
-
Sep 17, 2024 |
breakingcancernews.com | Sevginur Akdas
In December 2022, President Joe Biden signed a groundbreaking law permitting researchers to test drug candidates on human-based models or computer models before conducting human trials. This law has changed the long-standing requirement, dating back to the 1930s, that mandated drug and vaccine testing on both rodent and non-rodent species.
-
Aug 27, 2024 |
breakingcancernews.com | Sevginur Akdas
Cancer is a major public health issue worldwide, and it has been predicted that there will be 26 million new cases by 2030. The disease presents numerous challenges, not the least of which are resistance to treatment and its ability to spread to other tissues. The main reason for these challenges is the presence of cancer stem cells, which have been known for many years.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →